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Herpes Simplex Virus 1 Protein UL37 Interacts with Viral
Glycoprotein gK and Membrane Protein UL20 and Functions in
Cytoplasmic Virion Envelopment
Nithya Jambunathan,a Dmitry Chouljenko,a Prashant Desai,b Anu-Susan Charles,a Ramesh Subramanian,a Vladimir N. Chouljenko,a
Konstantin G. Kousoulasa
Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge,
Louisiana, USAa; Molecular Virology Laboratories, Viral Oncology Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins
University, Baltimore, Maryland, USAb

We have shown that glycoprotein K (gK) and its interacting partner, the UL20 protein, play crucial roles in virion envelopment.
Specifically, virions lacking either gK or UL20 fail to acquire an envelope, thus causing accumulation of capsids in the cytoplasm
of infected cells. The herpes simplex virus 1 (HSV-1) UL37 protein has also been implicated in cytoplasmic virion envelopment.
To further investigate the role of UL37 in virion envelopment, the recombinant virus DC480 was constructed by insertion of a
12-amino-acid protein C (protC) epitope tag within the UL37 amino acid sequence immediately after amino acid 480. The
DC480 mutant virus expressed full-size UL37 as detected by the anti-protC antibody in Western immunoblots, accumulated
unenveloped capsids in the cytoplasm of infected cells, and produced very small plaques on African green monkey kidney (Vero)
cells that were similar in size to those produced by the UL20-null and UL37-null viruses. The DC480 virus replicated nearly 4 log
less efficiently than the parental wild-type virus when grown on Vero cells. However, DC480 mutant virus titers increased nearly
20-fold when the virus was grown on FRT cells engineered to express the UL20 gene in comparison to the titers on Vero cells,
while the UL37-null virus replicated approximately 20-fold less efficiently than the DC480 virus on FRT cells. Coimmunoprecipitation experiments and proximity ligation assays showed that gK and UL20 interact with the UL37 protein in infected cells.
Collectively, these results indicate that UL37 interacts with the gK-UL20 protein complex to facilitate cytoplasmic virion envelopment.
IMPORTANCE

Herpes simplex viruses acquire their final envelopes by budding into cytoplasmic membranes derived from the trans-Golgi network (TGN). The tegument proteins UL36 and UL37 are known to be transported to the TGN sites of virus envelopment and to
function in virion envelopment, since mutants lacking UL37 accumulate capsids in the cytoplasm that are unable to bud into
TGN membranes. Viral glycoprotein K (gK) also functions in cytoplasmic envelopment, in a protein complex with the membrane-associated protein UL20 (UL20mp). This work shows for the first time that the UL37 protein functionally interacts with
gK and UL20 to facilitate cytoplasmic virion envelopment. This work may lead to the design of specific drugs that can interrupt
UL37 interactions with the gK-UL20 protein complex, providing new ways to combat herpesviral infections.

T

he herpes simplex virus 1 (HSV-1) double-stranded DNA genome is enclosed in an icosahedral capsid and embedded
within a proteinaceous tegument containing multiple viral proteins, all of which is packaged within an envelope decorated with
multiple membrane proteins and glycoproteins (1–5). HSV-1 encodes at least 26 tegument proteins and 11 glycoproteins as well as
several nonglycosylated membrane-associated proteins. The final
steps in virion envelopment occur in the cytoplasm of infected
cells and involve multiple interactions among viral proteins, including interaction between cytoplasmic portions of viral glycoproteins and tegument proteins bound to cytoplasmic capsids, as
well as tegument-tegument protein interactions (1, 6–9).
HSV-1 UL37 is an approximately 120-kDa phosphorylated
tegument protein expressed in both mature virions and light particles (10). The UL37 protein localizes to both the nucleus and
cytoplasm in infected cells. The UL37 cytoplasmic localization is
considered to be due to the presence of a nuclear export signal
(NES) sequence within the UL37 protein that mediates transport
of the UL37 protein to the cytoplasm in the absence of any other
viral proteins (3, 11–13). The UL37 protein is capable of self-
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association and interacts via its carboxyl terminus with the UL36
major tegument protein, and this interaction is necessary and sufficient for transport of the UL36-UL37 protein complex to the
trans-Golgi network (TGN), where virion envelopment is thought
to occur (11, 14–16).
Deletion of the UL37 gene specified by either HSV-1 or pseudorabies virus (PRV) inhibits cytoplasmic virion envelopment,
causing the accumulation of unenveloped capsids in the cytoplasm of infected cells (17–19). However, while the UL37 gene is
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ABSTRACT

absolutely essential for HSV-1 replication, deletion of the PRV
UL37 gene allows the resultant mutant virus to replicate, albeit
100-fold less efficiently than the parental wild-type virus, thus
demonstrating that certain PRV UL37 functions may be shared
with other PRV proteins (17, 20). The pUL36 protein in the UL37UL36 protein complex is thought to recruit the microtubule motors dynein, kinesin-1, and kinesin-2 onto capsids in the cytosol
(21). These interactions are further supported by in vitro experiments in which capsids complexed with inner tegument proteins
were able to associate with the microtubule motors, while the
capsids lacking the tegument proteins did not (22). Thus, the
UL37 protein plays important roles in capsid trafficking during
virion entry, in a retrograde manner, i.e., toward the nucleus, and
in conjunction with dynein motors and the microtubular network, while also playing an important role in capsid transport to
the TGN (23–28).
The UL36-UL37 protein complex is part of a multiprotein
complex within the virion particle and within infected cells. Specifically, the UL36 protein interacts with the outer tegument protein pUL48 (5) and the minor capsid protein UL25 (29). Additionally, the UL37 protein interacts with the UL46 and UL35
proteins (30). Also, it has been reported that UL37 is phosphorylated by cellular enzymes and that it interacts in the cytoplasm
with ICP8, the major HSV-1 DNA binding protein, and is transported to the nuclei of infected cells (10). The HSV-1 UL37 protein contains a TRAF6 (tumor necrosis factor receptor-associated
factor 6) binding domain that binds to TRAF6 and activates
NF-B expression, required for efficient viral replication, in a
Toll-like receptor 2 (TLR2)-independent manner (31). These results suggest that the UL37 protein specifies additional functions
in viral replication beyond its role in virion entry and cytoplasmic
virion envelopment.
HSV-1 gK is a multimembrane-spanning viral glycoprotein
encoded by the UL53 gene. It is expressed on virions, exists as a
functional complex with the membrane-associated UL20 viral
protein, and plays a role in both virion entry and cytoplasmic
virion envelopment (32–34). The functions of the gK-UL20 protein complex in virion entry and cytoplasmic virion envelopment
can be segregated genetically and physically from each other (34–
39). Functions of gK-UL20 in virion entry involve direct interactions of the amino termini of both gK and UL20 with the fusogenic
viral glycoprotein gB as well as with the membrane fusion regulator glycoprotein gH (35). These glycoproteins regulate fusion of
the viral envelope with cellular membranes during virus entry, as
well as virus-induced cell-to-cell fusion, i.e., formation of multinucleated cells (syncytia) which allow the virus to spread from cell
to cell (40–43).
Here we demonstrate for the first time that the UL37 protein
physically interacts with both gK and UL20 proteins in infected
cells. Moreover, overexpression of the UL20 protein in FRT cells
complements viral replication of the UL37 mutant DC480 virus,
which is unable to acquire cytoplasmic envelopes, suggesting that
the gK-UL20 interactions with UL37 facilitate cytoplasmic virion
envelopment.
MATERIALS AND METHODS
Cell lines. African green monkey kidney (Vero) cells were obtained from
the American Type Culture Collection (Rockville, MD). The Vero-based
UL37-complementing cell line BD45 was a gift from Prashant Desai
(Johns Hopkins University, Baltimore, MD). The construction and use of
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the UL20-expressing FRT/UL20 cell line were detailed previously (39).
The gK-transformed cell line VK302 was a gift from David C. Johnson
(Oregon Health Sciences University, Portland, OR). All cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco-BRL, Grand Island, NY) supplemented with 10% fetal calf serum and antibiotics.
Construction of HSV-1 mutant viruses. Mutagenesis was accomplished in Escherichia coli by using the markerless two-step Red recombination mutagenesis system and synthetic oligonucleotides (44, 45)
(DC480 Forward, GGGTCGAACGTGTTTGGTCTGGCGCGGGA
ATACGGGTACTATGCCAACTACGATTACAAGGATGACGACGA
TAAG; and DC480 Reverse, CCGCCCGTGCGTGTGCTCGCTGGCG
CCCTGGACCCGCCTGAAAGTTTTTACCTTGCCATCGATCAGTCG
CGGATCCACCTGGTCTCGTAGTTGGCATAGTACCCGTACAACC
AATTAACCAATTCTGATTAG) implemented on the bacterial artificial
chromosome (BAC) plasmid pYEbac102 carrying the HSV-1(F) genome
(46) (a gift from Y. Kawaguchi, University of Tokyo, Japan). Construction
of the HSV-1 mutant virus ⌬UL20 (UL20-null) was described previously
(44). The DC480 recombinant virus was constructed by inserting a 12amino-acid epitope tag (EDQVDPRLIDGK) for protein C (protC tag)
into the HSV-1 UL37 gene immediately after the codon for amino acid
480 (Fig. 1). The recombinant mutant virus YE102-VC1 was modified to
express gK and UL20 genes containing V5 and 3⫻FLAG antigenic
epitopes, respectively, and was described previously (38). Construction of
the HSV-1 UL37-null mutant virus (generously provided by Prashant
Desai, Johns Hopkins University, Baltimore, MD) was described previously (17).
Confirmation of targeted mutations, recovery of infectious virus,
and plaque morphology analysis. HSV-1 BAC DNAs were purified from
50-ml overnight BAC cultures by use of a Qiagen large-construct kit (Qiagen, Valencia, CA). All mutated DNA regions were sequenced to verify the
presence of the desired mutations in BACs. Similarly, viruses recovered
from infected Vero cells were sequenced to confirm the presence of the
desired mutations. Viruses were recovered from cells transfected with
BACs as described previously (44). Visual analysis of the plaque morphology of mutant viruses was performed as previously described (39, 42,
44, 47).
Viral growth kinetics. Analysis of viral growth kinetics was performed
as we described previously (32, 36). Briefly, nearly confluent Vero cell
monolayers were infected with each virus at 4°C for 1 h at a multiplicity of
infection (MOI) of 0.2. Thereafter, plates were incubated at 37°C and 5%
CO2, and virus was allowed to penetrate for 1 h at 37°C. Any remaining
extracellular virus was inactivated by low-pH treatment (pH 3.0), and
cells were incubated at 37°C and 5% CO2.
Electron microscopy. The ultrastructural morphology of virions
within infected cells was examined by transmission electron microscopy
essentially as described previously (37, 42, 44, 48, 49). All infected cells
processed for electron microscopy were prepared at 18 h postinfection
(hpi) and visualized on a JEOL transmission electron microscope.
Quantitative PCR (qPCR) analysis of cytoplasmic virions. Cytoplasmic virions were separated by glycerol shock treatment essentially as originally described by Sarmiento and Batterson (50) and later modified by
our laboratory (1). Real-time PCR was carried out on viral DNA from the
cytoplasmic fractions of Vero cells. Specifically, the primers and probe
(6-carboxytetramethylrhodamine [TAMRA]) for the real-time PCR were
designed to detect HSV-1 US6 (gD) (gD forward primer, ACGTACCTG
CGGCTCGTGAAGA; probe, 6-carboxyfluorescein [FAM]-GCCAAGGG
CTCCTGTAAGTACGCCCT-TAMRA; and gD reverse primer, TCACCC
CCTGCTGGTAGGCC). The cytoplasmic suspensions were treated with
Turbo DNase I (Ambion, Inc.) for 1 h at 37°C. Viral DNA was extracted
using a DNeasy blood and tissue kit (Qiagen, Inc.) per the manufacturer’s
instructions. Equal volumes of viral DNA were used for TaqMan PCR
analysis. Purified HSV-1 bacterial artificial chromosome (YE102) DNA
was used to generate the standard curve (1).
Immunoprecipitation and immunoblot assays. Confluent Vero cells
in T75 flasks were infected with the double-tagged recombinant virus
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FIG 1 Schematics of recombinant viruses and the UL37 gene. (A) Schematic arrangements of the wild-type (WT) virus and mutant viruses VC1 and DC480, with
the unique long (UL) and unique short (US) regions flanked by the terminal repeat (TR) and internal repeat (IR) regions. The VC1 virus expresses UL20 and gK
tagged with 3⫻FLAG and V5 epitope tags, respectively. The DC480 virus contains a 12-amino-acid (aa) protein C epitope tag inserted in frame immediately
following amino acid 480. (B) Schematic of the UL37 protein showing its functional domains. (C) Western immunoblot of cell extracts obtained from Vero cells
infected with the DC480 virus, using anti-protC antibody. Lane 1, wild-type virus-infected cellular extracts; lane 2, DC480 virus-infected cellular extracts.

YE102-VC1 (gK-V5 and UL20-FLAG) or the UL37-null virus at an MOI
of 2. At 24 hpi, the infected cells were lysed with NP-40 cell lysis buffer
(Life Technologies) supplemented with protease inhibitor tablets
(Roche). The samples were centrifuged at 13,000 rpm for 10 min at 4°C.
The supernatants were then used for immunoprecipitation. The proteins
from virus-infected cells were immunoprecipitated using protein G magnetic Dynabeads according to the manufacturer’s instructions (Invitrogen). Briefly, the beads were bound to their respective antibodies and left
on a nutator for 10 min, followed by the addition of cell lysates. The
lysate-bead mixture was kept on the nutator for 10 min at room temperature and subsequently washed three times with phosphate-buffered saline (PBS). The protein was eluted from the magnetic beads in 40 l of
elution buffer and used for immunoblot assays. Sample buffer containing
5% ␤-mercaptoethanol was added to the protein and heated at 55°C for 15
min. Proteins were resolved in a 4 to 20% SDS-PAGE gel and immobilized
on nitrocellulose membranes. For Western immunoblots, subconfluent
Vero cell monolayers were infected with the indicated virus at an MOI of
3. At 24 hpi, cells were collected by low-speed centrifugation, washed with
PBS, and processed as described previously (34, 44). Immunoblot assays
were carried out using monoclonal mouse anti-protein C antibody
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(Abcam, Cambridge, England), monoclonal mouse anti-VP5 antibody
(Abcam, Inc., Cambridge, MA), monoclonal mouse anti-FLAG antibody (Sigma-Aldrich, Inc., St. Louis, MO), monoclonal mouse anti-V5 antibody (Invitrogen), horseradish peroxidase (HRP)-conjugated goat anti-mouse antibodies against the light chain (Fab) and
heavy chain (Fc) (Abcam, Inc., Cambridge, MA), polyclonal rabbit
anti-UL37 antibody (a gift from Frank J. Jenkins, University of Pittsburgh Cancer Institute), and HRP-conjugated goat anti-rabbit antibody (Abcam, Inc., Cambridge, MA).
In situ PLA of protein interactions in virus-infected cells. Vero cells
were grown on 8-well chamber slides (Nunc Lab-Tek II chamber slide
system) and infected with F strain virus (untagged) or the tagged virus
VC1 (gK-V5 and UL20-FLAG) at an MOI of 10. At 18 h postinfection, the
cells were fixed with ice-cold methanol for 10 min at ⫺20°C. After three
washes with PBS, the samples were blocked for 2 h at 37°C with Duolink
blocking buffer in a humidity chamber. Primary antibodies that were
raised in two different species were diluted in antibody diluting buffer,
added to the samples, and incubated overnight at 4°C. Mouse anti-V5
antibody (Invitrogen) and rabbit anti-FLAG antibody (Sigma-Aldrich,
Inc., St. Louis, MO) were used for gK and UL20 detection, respectively
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FIG 2 Representative plaque morphologies of wild-type and mutant viruses.

(positive control). Mouse anti-FLAG and rabbit anti-UL37 antibodies
were used for the HSV-1(F)-infected (virus with no epitope tags) and
VC1-infected cells to detect UL20-UL37 interaction. Mouse anti-V5 and
rabbit anti-UL37 antibodies were used for HSV-1(F)- and VC1-infected
cells to detect gK-UL37 interaction. Mouse anti-ICP8 (Abcam) and rabbit
anti-FLAG were used to detect ICP8-UL20 interaction. Unbound primary
antibodies were removed by washing with 1⫻ Tris-buffered saline (TBS)–
Tween 20 (0.05%) three times for 5 min each. Duolink Anti-Rabbit Plus
and Anti-Mouse Minus in situ proximity ligation assay (PLA) probes were
added to the samples (1:5 dilution) and incubated at 37°C for 1 h. After the
incubation step, washes were done with Duolink wash buffer A, twice for
5 min each. The ligation stock was diluted 1:5 in high-purity water and
added to the wells (40 to 80 l), and the slides were incubated at 37°C for
30 min. The slides were washed with buffer A three times for 5 min each,
amplification solution (40 to 50 l) was added, and the slides were incubated for 1.5 h at 37°C. The slides were then washed with wash buffer B
twice for 10 min each, and once with 0.01% buffer B. The slides were
mounted with mounting medium (Duolink II), stored at ⫺20°C, and
protected from light until confocal images were taken. The confocal images were taken using a 60⫻ objective on an Olympus Fluoview FV10i
confocal laser scanning microscope.

RESULTS

Construction and characterization of UL37 mutant viruses. The
recombinant virus DC480 was constructed by insertion of a protein C (protC) epitope tag immediately after the UL37 gene region
encoding amino acid 480 (Fig. 1A). The protC epitope tag was
inserted in frame immediately after a conserved tyrosine residue
located within the central portion of UL37, distal to known functional domains of UL37 (Fig. 1B). Expression of the UL37-protCtagged protein was confirmed by Western immunoblot analysis
with anti-protC antibody. The UL37-protC construct was detected as a protein species migrating with an apparent electrophoretic mobility of approximately 120 to 130 kDa (Fig. 1C), in agreement with previously published reports (3, 11, 51).
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FIG 3 Replication kinetics of wild-type and mutant viruses. Confluent Vero
(A) or FRT (B) cell monolayers were infected with each virus shown at an MOI
of 0.2. Viral titers were obtained by plaque assay on the appropriate cell lines.
The titers obtained were averaged, and the standard error of the mean was
calculated for each time point.

Plaque morphology and replication kinetics of the DC480
recombinant virus. The DC480 virus produced very small viral
plaques on Vero and VK302 cells that were similar in appearance
to those produced by the UL20-null virus and comprised, on average, 5 to 10 cells, but it formed nearly wild-type-like viral
plaques on BD45 cells expressing the UL37 gene (Fig. 2). The
UL37-null virus produced very small viral plaques on Vero,
VK302, and FRT cells but formed wild-type-like plaques on BD45
cells. The UL20-null virus formed wild-type-like viral plaques on
the FRT cell line expressing the UL20 gene, as expected. Interestingly,
the DC480 virus formed plaques on FRT cells that were approximately 5 to 10 times larger than the plaques produced by the same
virus on Vero or VK302 cells (Fig. 2). We reported previously that a
lack of UL20 gene expression inhibits infectious virus production (39,
48). The DC480 virus replicated substantially less efficiently than the
UL20-null virus in Vero cells, producing infectious virion titers that
were nearly 4 log lower than those of the wild-type virus at late times
postinfection, while the UL20-null titers were approximately 2 1/2 log
lower than those of the wild-type virus (Fig. 3A). In contrast, the
DC480 virus replicated nearly 20-fold more efficiently in FRT cells
than in Vero cells, while the wild-type virus replicated equally efficiently in both FRT and Vero cells (Fig. 3B). The replication efficiency
of the UL37-null virus on FRT cells was approximately 20-fold lower
than that of the DC480 virus. As expected, the UL20-null virus was
able to replicate in FRT cells substantially better than in Vero cells,
although final titers remained lower than those of the wild-type virus
(Fig. 3A and B).
Evaluation of envelopment efficiencies of the DC480 virus.
Ultrastructural visualization of infected cells revealed that the
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Vero, BD45 (UL37 expressing), FRT (UL20 expressing), and VK302 (gK expressing) cell monolayers were infected at an MOI of 0.001, and viral plaques
were visualized by immunohistochemistry using polyclonal rabbit anti-HSV-1
antibody at 48 hpi.

FIG 4 Ultrastructural morphology of wild-type and mutant viruses. Electron micrographs of Vero or BD45 cells infected at an MOI of 3 with wild-type or DC480
virus and processed for electron microscopy at 18 hpi are shown. Enlarged sections of the micrographs are included as insets. The nucleus (n), cytoplasm (c), and
extracellular space (e) are marked. Representative virions are marked with black arrowheads.

DC480 virus exhibited drastic defects in virion envelopment, as
evidenced by the accumulation of unenveloped capsids in the cytoplasm of infected Vero cells and the absence of enveloped virions extracellularly, as previously reported for the UL37-null virus
(17, 28), in comparison to wild-type virus infection. In contrast,
the DC480 virions appeared to be egressing efficiently out of BD45
cells (Fig. 4).
We previously described the use of qPCR for determination of
the relative efficiency of viral cytoplasmic envelopment (1). In this
assay, the total number of viral genomes found within DNaseresistant viral capsids is determined via qPCR and compared to
the number of infectious virions obtained by plaque assay. The
wild-type virus was efficiently enveloped and formed into infectious virions in both Vero and BD45 cells at an MOI of 1. In
contrast, the viral envelopment and infectious virion production efficiency of the DC480 virus were inhibited ⬎700-fold in
Vero cells in comparison to BD45 cells. Ratios of the numbers
of encapsidated DC480 viral genomes and PFU were only approximately 2-fold lower than that of the wild-type virus on
BD45 cells (Fig. 5).
Determination of UL37 interactions with gK and UL20. To
evaluate whether the UL37 protein interacts physically with either
gK or the UL20 membrane protein, coimmunoprecipitation experiments were performed using the VC1 virus (Fig. 1A), which
expresses gK tagged with a V5 epitope inserted in frame within the
amino terminus of gK and UL20 tagged with a 3⫻FLAG epitope
inserted in frame after amino acid 4 of the UL20 protein (38).

June 2014 Volume 88 Number 11

FIG 5 Determination of relative efficiencies of virion envelopment of wildtype and mutant viruses in Vero or BD45 cells. The total number of viral
genomes in the cytoplasm of infected Vero or BD45 cells at 24 hpi that were
protected from DNase I treatment was obtained by qPCR. The total number of intracellular infectious virions was obtained by plaque assay. Ratios
reflecting relative efficiencies of envelopment and infectious virion production were obtained by dividing the average number of capsid-protected
viral genomes by the number of PFU. Error bars represent standard errors
of the means.

jvi.asm.org 5931

Downloaded from https://journals.asm.org/journal/jvi on 14 January 2022 by 2620:105:b001:1060:86f:667c:32f5:4ae9.

Roles of gK, UL20, and UL37 in Virion Envelopment

FIG 6 Western immunoblots of infected cell lysates and anti-UL37, anti-gK,
and anti-UL20 immunoprecipitates. Vero cells were infected with the doubletagged virus YE102-VC1, expressing gK tagged with the V5 epitope tag and
UL20 tagged with the 3⫻FLAG epitope, or with UL37-null virus. Infected cell
lysates were obtained at 24 hpi, and immunoprecipitates were obtained using
anti-gK (anti-V5; gK-IP), anti-UL20 (anti-FLAG; UL20-IP), and anti-UL37
(UL37-IP) antibodies in conjunction with magnetic beads. Immunoprecipitates were electrophoretically separated by SDS-PAGE and transferred to
nitrocellulose membranes. The blots were probed with rabbit anti-UL37 antibody and HRP-conjugated secondary anti-rabbit antibody (A), mouse antiFLAG antibody and HRP-conjugated goat anti-mouse antibody against heavy
chain (Fc) (B), mouse anti-VP5 antibody and HRP-conjugated goat antimouse antibody (C), or mouse anti-V5 antibody and HRP-conjugated goat
anti-mouse antibody against light chain (Fab) (D). In panels B, C, and D, lanes
labeled “lysate” denote cellular extracts of VC1, and the other lanes represent
immunoprecipitated samples from VC1-infected cells.

Detection of the UL37 protein was achieved by using a rabbit
anti-UL37 polyclonal antibody (3). The UL37 protein was detected as migrating with an apparent molecular mass of 130 kDa
(Fig. 6A, arrow). Immunoprecipitation of cellular extracts obtained from wild-type-infected cells by use of the UL37 antibody
and subsequent immunoblot detection by the UL37 antibody
showed a UL37-specific protein species migrating with an apparent molecular mass of 130 kDa (Fig. 6A). However, this 130-kDa
protein species was absent in the lysate and the immunoprecipitates from the UL37-null virus (Fig. 6A). Immunoblot probing of
immunoprecipitates of the UL20 protein with the anti-3⫻FLAG
antibody or immunoprecipitates of gK with the anti-V5 antibody
readily detected the presence of the UL37 protein migrating at
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approximately 130 kDa (Fig. 6A). Immunoblot probing of infected lysate extracts with the anti-UL20 (anti-3⫻FLAG) antibody
revealed the presence of UL20 migrating with an apparent molecular mass of approximately 28 kDa (Fig. 6B), as we reported previously (35). The UL20 protein was also readily detected in UL20,
gK, and UL37 immunoprecipitates (Fig. 6B). The UL20 protein
failed to immunoprecipitate VP5, while VP5 was readily detected
in the lysate, migrating with an apparent molecular mass of 150
kDa (Fig. 6C) when probed with anti-VP5 antibody. Immunoblot
probing with the anti-gK (anti-V5) antibody readily detected gK
in VC1 virus-infected cell extracts (Fig. 6D) as well as gK, UL20,
and UL37 immunoprecipitates. Although the apparent molecular
mass of gK is approximately 38 kDa (32, 52), larger gK-related
protein species were detected in UL20 and UL37 immunoprecipitates, presumably due to gK-UL20-UL37 protein complexes that
were not fully resolved to individual protein species (Fig. 6D).
Determination of UL37 interactions with gK and UL20 by
PLA. To further validate the observed interactions of the UL37
protein with gK and the UL20 membrane protein, we utilized
PLA. In this assay, primary antibodies against UL37, gK (anti-V5),
and UL20 (anti-3⫻FLAG) are first bound to their respective antigens. Species-specific secondary antibodies, called PLA probes,
each having a unique short DNA primer covalently attached, are
used to bind to the primary antibodies. When the PLA probes are
in close proximity, the DNA primers can interact through two
other circle-forming oligonucleotides that are added later. Enzymatic ligation of these two fluorescently labeled oligonucleotides
followed by polymerase-dependent rolling circle amplification results in the generation of intense fluorescence, which is visualized
as distinct bright spots by use of a fluorescence microscope. This
assay can determine even transient or weak intracellular interactions (53, 54). PLA readily detected the known gK-UL20 interactions (Fig. 7F). Potential interactions were also detected between
UL20 and UL37 (Fig. 7B) and between gK and UL37 (Fig. 7E),
while wild-type virus-infected cells did not exhibit fluorescence
signals (Fig. 7A and D). The fluorescence signals were also absent
in our ICP8-UL20 control, suggesting the absence of potential
interaction between these proteins (Fig. 7C).
DISCUSSION

HSV-1 cytoplasmic virion envelopment involves multiple interactions among viral glycoproteins and tegument proteins. The
UL37 protein has been shown to be transported, in complex with
the UL36 protein and in a capsid-independent manner, to the
TGN, where it functions in cytoplasmic virion envelopment. Here
we describe the phenotypic and replication properties of the UL37
mutant virus DC480, which contains a 12-amino-acid epitope tag
inserted in frame at approximately the middle portion of the UL37
protein. The DC480 virus exhibits drastic defects in cytoplasmic
virion envelopment, similar to those of mutant viruses lacking
either the gK or UL20 gene. Partial complementation of the UL37
mutant virus in UL20-expressing FRT cells, along with coimmunoprecipitation experiments, revealed that the UL37 protein interacts with gK and UL20, suggesting that these interactions facilitate cytoplasmic virion envelopment.
Functional domains of the UL37 protein. The UL37 protein
contains multiple domains that appear to have distinct functions
during virus replication. To facilitate detection of the UL37 protein, we inserted a protC epitope tag within the central portion of
the UL37 protein, distal to the amino acid regions that are known
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anti-3⫻FLAG rabbit antibody), anti-ICP8 (mouse), and anti-gK (anti-V5 mouse antibody) antibodies in conjunction with appropriate secondary antibodies and
oligonucleotides as described in Materials and Methods. Fluorescence images of cells infected with wild-type or VC1 virus were recorded using an Olympus
confocal microscope at 18 hpi. (A and B) HSV-1(F)- and HSV-1(VC1)-infected Vero cells treated with anti-FLAG (anti-UL20) and anti-UL37 antibodies,
respectively. (C) HSV-1(VC1)-infected Vero cells treated with anti-FLAG (anti-UL20) and anti-ICP8 antibodies. (D and E) HSV-1(F)- and HSV-1(VC1)infected Vero cells treated with anti-V5 (anti-gK) and anti-UL37 antibodies, respectively. (F) HSV-1(VC1)-infected Vero cells treated with anti-V5 (anti-gK) and
anti-FLAG (anti-UL20) antibodies.

to be involved in UL37 self-association, to bind to the UL36 protein, or to contain other known functional domains (Fig. 1). The
mutant DC480 virus expressed a full-length UL37 protein that was
readily detectable by Western immunoblots using anti-protC antibody. However, this epitope insertion resulted in a severe cytoplasmic envelopment defect similar to that of the UL37-null virus,
as evidenced by ultrastructural examination of infected cells
showing accumulation of unenveloped capsids in the cytoplasm.
This apparent defect in cytoplasmic virion envelopment in the
DC480 virus was further supported by highly elevated DNaseresistant particle-to-PFU ratios in comparison to those for wildtype virus infections. Alignment of a large subset of known UL37
amino acid sequences revealed the presence of highly conserved
residues among the alphaherpesviruses, as noted previously (55).
The protC epitope tag insertion was specifically targeted to be
immediately adjacent to a highly conserved tyrosine (Y) residue at
amino acid position 480. UL37 is also reported to be phosphorylated in infected cells (10). Reversible phosphorylation can result
in conformational changes that can significantly alter the functions of proteins, as evidenced by the regulation of the p53 tumor
suppressor protein via phosphorylation (56). Tyrosine sulfation is
also a widespread posttranslational modification of eukaryotic
proteins that modulate protein-protein interactions (57). Thus, it
is possible that the protC epitope insertion alters Y-specific posttranslational modifications of the UL37 protein or alters proteinprotein interactions that directly involve the amino acid region
immediately adjacent to the conserved Y residue. Alternatively,
disruption of this UL37 domain by the protC epitope insertion
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may change the overall conformation of the protein, thus affecting
other functional domains of the UL37 protein. It has been shown
that the UL37 protein is phosphorylated by cellular enzymes and
that it interacts in the cytoplasm with the major DNA binding
protein, ICP8. UL37 interactions with ICP8 enable transport of
the UL37 protein to the nuclei of infected cells away from the
cytoplasm; therefore, the UL37-ICP8 interactions are not likely to
play a role in cytoplasmic virion envelopment (10).
As expected, both the DC480 and UL37-null viruses were efficiently complemented for virus replication and spread on BD45
cells transformed with an HSV-1 gene fragment containing the
UL37 gene (17). Surprisingly, the DC480 virus was also complemented for virus replication and virus spread in FRT cells expressing the UL20 gene under the control of its native promoter, while
the UL37-null virus was not. The observed DC480 virus complementation for virus growth on UL20-expressing FRT cells
strongly suggests direct or indirect physical interactions between
the UL37 protein and the UL20-gK protein complex. Coimmunoprecipitation experiments using the available anti-UL37 polyclonal antibody and either gK or UL20, tagged with a V5 or
3⫻FLAG epitope tag, respectively, showed that the UL37 protein
interacted with both gK and UL20 in infected cells, thus providing
additional evidence for physical interactions between UL37 and
the gK-UL20 protein complex. It has been reported previously
that the UL36-UL37 complex migrates to TGN membranes in the
absence of capsids (11). There was no VP5 protein detected in
UL20 immunoprecipitates, suggesting that the observed interactions between UL20 and gK involved a UL37 protein that was not
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FIG 7 PLA to determine UL37 interactions with gK and UL20. PLA was performed using anti-UL37 (rabbit), anti-UL20 (anti-3⫻FLAG mouse antibody or

attached to viral capsids. The UL37-UL36 protein complex may
interact with gK-UL20 after its intracellular transport to TGN
membranes. Alternatively, the UL36-UL37 protein complex may
interact with gK-UL20 in the endoplasmic reticulum and be
cotransported to the TGN sites of virion envelopment. Additional
experiments are required to distinguish between these two possibilities.
We have shown that the gK-UL20 protein complex plays critical roles in cytoplasmic virion envelopment and egress from infected cells. Our current results as well as previous reports (11,
14–16) clearly indicate that the highly conserved UL37 protein is a
crucial determinant for cytoplasmic virion envelopment. Thus,
the facts that these two protein complexes (gK-UL20 and UL36UL37) interact within infected cells and at TGN sites and are involved in cytoplasmic virion envelopment are not surprising. Similar interactions must occur within the virion particle, suggesting
that during virion entry these interactions must be regulated to
allow the capsid to enter into the cytoplasm, while virion envelopes and their glycoprotein content remain fused with cellular
plasma membranes. Interactions of viral glycoproteins, including
gK and its partner protein, UL20, with cellular receptors may trigger inhibition of the UL36-UL37 interactions with the gK-UL20
protein complex. Additional work is required to investigate these
possibilities.
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